These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27814647)

  • 1. Role of JNK isoforms in the kainic acid experimental model of epilepsy and neurodegeneration.
    Auladell C; de Lemos L; Verdaguer E; Ettcheto M; Busquets O; Lazarowski A; Beas-Zarate C; Olloquequi J; Folch J; Camins A
    Front Biosci (Landmark Ed); 2017 Jan; 22(5):795-814. PubMed ID: 27814647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective Effects of the Absence of JNK1 or JNK3 Isoforms on Kainic Acid-Induced Temporal Lobe Epilepsy-Like Symptoms.
    de Lemos L; Junyent F; Camins A; Castro-Torres RD; Folch J; Olloquequi J; Beas-Zarate C; Verdaguer E; Auladell C
    Mol Neurobiol; 2018 May; 55(5):4437-4452. PubMed ID: 28664455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK Isoforms Are Involved in the Control of Adult Hippocampal Neurogenesis in Mice, Both in Physiological Conditions and in an Experimental Model of Temporal Lobe Epilepsy.
    Castro-Torres RD; Landa J; Rabaza M; Busquets O; Olloquequi J; Ettcheto M; Beas-Zarate C; Folch J; Camins A; Auladell C; Verdaguer E
    Mol Neurobiol; 2019 Aug; 56(8):5856-5865. PubMed ID: 30685843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JNK1 inhibition by Licochalcone A leads to neuronal protection against excitotoxic insults derived of kainic acid.
    Busquets O; Ettcheto M; Verdaguer E; Castro-Torres RD; Auladell C; Beas-Zarate C; Folch J; Camins A
    Neuropharmacology; 2018 Mar; 131():440-452. PubMed ID: 29111385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration.
    Barnat M; Enslen H; Propst F; Davis RJ; Soares S; Nothias F
    J Neurosci; 2010 Jun; 30(23):7804-16. PubMed ID: 20534829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background.
    Schauwecker PE
    Brain Res; 2000 Nov; 884(1--2):116-28. PubMed ID: 11082493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice.
    Harder JM; Williams PA; Soto I; Foxworth NE; Fernandes KA; Freeburg NF; Libby RT; John SWM
    Cell Death Dis; 2018 Jun; 9(6):705. PubMed ID: 29899326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of Jun-N-terminal kinase 3 (JNK3) does not protect against neurodegeneration induced by 3-nitropropionic acid.
    Junyent F; de Lemos L; Verdaguer E; Pallàs M; Folch J; Beas-Zárate C; Camins A; Auladell C
    Neuropathol Appl Neurobiol; 2012 Jun; 38(4):311-21. PubMed ID: 21883373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion attenuates kainic acid-induced seizures and neuronal cell death in rat hippocampus.
    Lin KC; Wang CC; Wang SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():207-14. PubMed ID: 23770308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Jun N-terminal kinase signaling pathway in excitotoxic cell death following kainic acid-induced status epilepticus.
    Spigolon G; Veronesi C; Bonny C; Vercelli A
    Eur J Neurosci; 2010 Apr; 31(7):1261-72. PubMed ID: 20345908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding.
    Carulla P; Bribián A; Rangel A; Gavín R; Ferrer I; Caelles C; Del Río JA; Llorens F
    Mol Biol Cell; 2011 Sep; 22(17):3041-54. PubMed ID: 21757544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria.
    Zhao Y; Spigolon G; Bonny C; Culman J; Vercelli A; Herdegen T
    Mol Cell Neurosci; 2012 Mar; 49(3):300-10. PubMed ID: 22206897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
    Ito M; Yoshioka K; Akechi M; Yamashita S; Takamatsu N; Sugiyama K; Hibi M; Nakabeppu Y; Shiba T; Yamamoto KI
    Mol Cell Biol; 1999 Nov; 19(11):7539-48. PubMed ID: 10523642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene.
    Yang DD; Kuan CY; Whitmarsh AJ; Rincón M; Zheng TS; Davis RJ; Rakic P; Flavell RA
    Nature; 1997 Oct; 389(6653):865-70. PubMed ID: 9349820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of JIP3 on epileptic seizures: Evidence from temporal lobe epilepsy patients, kainic-induced acute seizures and pentylenetetrazole-induced kindled seizures.
    Wang Z; Chen Y; Lü Y; Chen X; Cheng L; Mi X; Xu X; Deng W; Zhang Y; Wang N; Li J; Li Y; Wang X
    Neuroscience; 2015 Aug; 300():314-24. PubMed ID: 26002316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral ischemia provokes a profound exchange of activated JNK isoforms in brain mitochondria.
    Zhao Y; Herdegen T
    Mol Cell Neurosci; 2009 Jun; 41(2):186-95. PubMed ID: 19289169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reduced susceptibility to chemoconvulsant stimulation in adenylyl cyclase 8 knockout mice.
    Chen X; Dong G; Zheng C; Wang H; Yun W; Zhou X
    Epilepsy Res; 2016 Jan; 119():24-9. PubMed ID: 26656781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JNK is activated but does not mediate hippocampal neuronal apoptosis in experimental neonatal pneumococcal meningitis.
    Sury MD; Agarinis C; Widmer HR; Leib SL; Christen S
    Neurobiol Dis; 2008 Oct; 32(1):142-50. PubMed ID: 18703144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific pathophysiological functions of JNK isoforms in the brain.
    Brecht S; Kirchhof R; Chromik A; Willesen M; Nicolaus T; Raivich G; Wessig J; Waetzig V; Goetz M; Claussen M; Pearse D; Kuan CY; Vaudano E; Behrens A; Wagner E; Flavell RA; Davis RJ; Herdegen T
    Eur J Neurosci; 2005 Jan; 21(2):363-77. PubMed ID: 15673436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment.
    de Lemos L; Junyent F; Verdaguer E; Folch J; Romero R; Pallàs M; Ferrer I; Auladell C; Camins A
    J Neurochem; 2010 Sep; 114(5):1315-22. PubMed ID: 20534003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.